| Cancer Therapy Pharmaceuticals_and_biotechnology > Critical therapies > Cancer Therapy |  |
Specializes in cancer prevention and detection.
National Cancer Institute, site of related information for patients, physicians, and lists of newly approved drugs.
Zarix, Ltd. was formed to identify opportunities for in-licensing and developing a novel portfolio of oncology compounds.
Proprietary drug delivery systems and therapeutic compounds to increase the effectiveness and reduce the side-effects of anti-cancer therapies.
Producer of biopharmaceuticals for mainly for cancer and tumors.
We market products in Anti-infective and Anti-cancer (oncology) - with developments in wound healing undergoing clinical trials.
Diatide (Nasdaq: DITI) is a specialty pharmaceutical company developing a line of disease-specific, diagnostic and therapeutic drugs for the treatment and diagnosis of life-threatening conditions such as cancer and cardiovascular disease.
Biopharmaceutical company dedicated to the treatment of cancer and allied diseases in the South African market.
Research and development in the area of immunology to promote the prevention and treatment of infectious disease and cancer.
Cardiology, internal medicine, gastroenterology, gynecology, anti-cancer products.
Engaged in the research, development and commercialization of unique antibody-based immunotherapeutics, initially for the treatment of cancer.
Pharmaceutical company focused on the development and commercialization of therapies for patients with cancer and allied diseases such as AIDS.
Developing cancer products, with a focus on cancer vaccines and angiogenesis inhibitors.
Bulk drugs that include cardio-vascular, epitepsy, animal health, anaesthesia, antiseptic and oncological preparations.
Company developing novel pharmaceuticals directed against AIDS, human cancers, glaucoma, and chronic inflammatory diseases.
Drug discovery and development company involved with small-molecule therapeutics for the treatment of cancer, chemotherapy-induced side effects and certain degenerative diseases.
Firm focused on the discovery and development of drug molecules that leverage the cycle of drug resistance in cancer and infectious disease.
Manufacturing and research and development company specializing in cancer therapies.
Headed by its founder and president Dr. Joseph S. D'Arrigo, the company's principal business is in the targeted-delivery R&D area.
Healthcare technology company focused on developing diagnostic products and treatments to improve the quality of women's health in the areas of cancer, pregnancy and reproductive health.
Company specializing in production of bulk pharmaceuticals with emphasis on anthracyclin chemotheratherapeutic agents. Outsourcing orders are welcome.
Involved in the development and application of innovative chemical technology for enhancing the utility of protein- and virus-based pharmaceuticals, especially in the management of cancer, the adverse effects of cancer therapy and severe gout.
Publicly-traded biopharmaceutical company that focuses on the diagnosis and treatment of cancer and autoimmune disease.
Biopharmaceutical company dedicated to the discovery, development and commercialization of efficient and innovative therapeutics in the area of cancer and cardiac disease.
Provider of rapidly emerging cell technology that assists oncologists in treating advanced cancers at their own facility. The company receives tumor cells from individual patients, cryogenically freezes them and creates tumor derived activated .
Manufacturer of vacuum systems and equipment including valves, pumps, vacuum systems, transducers, detection equipment and pressure controllers. Products are sold to multiple industries. This company was capitalized by corporate investment.
Developer of cancer therapies using technology derived from proteomics and glycomics.
Developer of cancer therapeutics, including small-molecule CDK inhibitors, small-molecule complexes and intelligent delivery and targeting systems.
Involved in the development of models to test the efficiency of anticancer therapies for preclinical in vivo assessment.
| Nb of links = 29 |